VERONICA PEREZ: Open Payments
NPI 1013552397 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 26 payments from 8 companies in 2025. Trend: 2023 $316 · 2024 $615 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $137 |
| PFIZER INC. | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Ardelyx, Inc. | 2 | $43 |
| Procept Biorobotics Corporation | 1 | $32 |
| Lilly USA, LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: JARDIANCE, Rybelsus, ELIQUIS, Ozempic, IBSRELA, AQUABEAM ROBOTIC SYSTEM, Wegovy, MOUNJARO.
Industry payments across FL — which companies pay providers there.
